相关实验视频
Updated: May 21, 2025

04:23
The Creation of a Rat Model for Osteosarcopenia via Ovariectomy
Published on: February 21, 2025
200
营养方法治疗糖尿病的萨尔科佩尼亚:一个全面的审查
1Faculty of Health Sciences, Department of Nutrition and Dietetics, Ondokuz Mayıs University, Samsun, Turkey. guleda.kilinc@omu.edu.tr.
Current nutrition reports
|March 19, 2025
概括
在患有2型糖尿病 (T2DM) 的老年人中,糖尿病性肉症 (DS) 需要特定的营养策略. 建议包括足够的卡路里和蛋白质摄入量,分支链氨基酸,抗氧化剂,以及可能的地中海饮食.
科学领域:
- 老年学是指老年学的学科.
- 内分泌学 在内分泌学.
- 营养科学 营养科学
背景情况:
- 2型糖尿病 (T2DM) 显著影响50岁以上的人,带来大量的医疗保健费用.
- 糖尿病皮症 (DS),糖尿病患者的肌肉质量和功能丧失,在老年人群中越来越令人担忧.
- 营养在管理T2DM及其相关并发症DS方面发挥着至关重要的作用.
研究的目的:
- 为了评估糖尿病 (DS) 和它与营养干预的复杂关系.
- 通过详细的文献审查,阐明DS的潜在机制.
- 提供关于DS和营养的当前文献的全面概述.
主要方法:
- 在主要的科学数据库 (Web of Science,Google Scholar,Scopus,Science Direct,PubMed) 中进行了全面的文献搜索.
- 该审查涵盖了从开始到2024年7月的研究.
- 专注于了解DS机制和营养管理策略.
主要成果:
- 营养治疗旨在增强肌肉质量,力量和身体表现,同时管理与糖尿病相关的代谢风险和葡萄糖水平.
- 对于患有DS的人来说,推的能量摄入量应该超过30千卡/公斤.
- 建议每天摄入至少1-1.2g/kg的蛋白质,强调饮食时间和富含分支链氨基酸 (BCAA) 的饮食.
- 富含抗氧化剂和充足的宏观/微量营养素的饮食很重要,地中海饮食是潜在的选择.
结论:
- 需要针对DS的具体饮食建议,强调进一步临床研究的重要性.
- 优化营养是改善患有糖尿病肉症的个体结果的关键.
- 目前的证据表明,管理DS的多方面的营养方法.
相关概念视频
Diabetes: Management and Pharmacotherapy
216
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
216
Carbohydrate Metabolism
10.7K
Carbohydrates are polymers composed of molecules containing atoms of carbon, hydrogen and oxygen. One gram of carbohydrate can provide four kilo-calories of energy, which makes it the most efficient instant energy source.
Starch accounts for approximately 60% of the carbohydrates consumed by humans. Since amylase enzymes cannot function in the stomach's acidic environment, starch can only be digested in the mouth and small intestine. Simple sugars are found naturally in milk and fruits in...
Starch accounts for approximately 60% of the carbohydrates consumed by humans. Since amylase enzymes cannot function in the stomach's acidic environment, starch can only be digested in the mouth and small intestine. Simple sugars are found naturally in milk and fruits in...
10.7K
Insulin: Dosing Regimen and Adverse Effects
134
Insulin-replacement therapy usually includes both long-acting insulin (basal) and short-acting insulin (to cater to postprandial needs). In a diverse group of type 1 diabetes patients, the average daily insulin dose is typically 0.5-0.7 units/kg body weight. However, obese patients and pubertal adolescents may need more due to insulin resistance.
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
134
Diabetes Mellitus: Type 2 and Gestational
2.1K
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
2.1K
Hypoglycemia and Glucagon
146
Without prolonged fasting, healthy individuals maintain blood glucose levels above 3.5 mM due to a well-adapted neuroendocrine counterregulatory system that effectively prevents acute hypoglycemia, a potentially life-threatening condition. The primary clinical scenarios for hypoglycemia encompass diabetes treatment, inappropriate production of endogenous insulin or insulin-like substances by tumors, and the use of glucose-lowering agents in non-diabetic individuals. Notably, hypoglycemia in the...
146
Oral Hypoglycemic Agents: Biguanides and Glitazones
148
Biguanides, particularly metformin (Glucophage), are insulin sensitizers that enhance glucose uptake, thereby reducing insulin resistance. Unlike sulfonylureas, metformin doesn't prompt insulin secretion, which helps to curb hypoglycemia risk. Metformin is beneficial in treating conditions like polycystic ovary syndrome due to its insulin-resistance reduction capability. The drug's primary action involves curtailing hepatic gluconeogenesis, a significant contributor to high blood...
148

